<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, seven trials, involving 182 participants, were included in our study. Six of the articles were CCTs [17âˆ’22], and one was an RCT [
 <xref rid="pone.0227532.ref023" ref-type="bibr">23</xref>]; they included 44 females and 138 males. In addition, all the HBV-GN patients had kidney biopsies; membranous nephropathy (MN) was found in 134 patients (73.6%), followed by IgA nephropathy in 24 (13.2%), membranoproliferative glomerulonephritis (MPGN) in 12 (6.6%), focal segmental glomerulosclerosis (FSGS) in four, other pathological types, such as mesangial proliferative glomerulonephritis (MSPGN) and minimal change nephropathy (MCGP), in two patients and IgM nephropathy in one patient. Two patients had combined lesions, with one having a combination of MN and MPGN and the other having FSGS and IgAN. The characteristics are described in 
 <xref rid="pone.0227532.t001" ref-type="table">Table 1</xref>.
</p>
